CONVIVO Endomicroscopy for Brain Tumor

This trial aims to explore how well the CONVIVO Endomicroscopy tool assists surgeons in viewing brain tissue details during surgery. By using this technology, doctors can better distinguish between healthy and abnormal brain tissues in real-time, potentially improving the accuracy of brain tumor surgeries. It targets patients needing surgery for brain tumors, particularly those with high-grade, invasive types. This trial may suit individuals with an intracranial lesion requiring surgery who have not experienced allergic reactions to fluorescein or have asthma. As an unphased trial, it offers patients the opportunity to contribute to innovative research that may enhance surgical outcomes.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Research has shown that the CONVIVO Endomicroscopy system is safe for use during brain surgery. Studies demonstrate that this technology provides real-time images of brain tissue without causing harm. In one study, the system successfully captured digital images without any reported negative side effects. Another study confirmed that the system is both safe and easy to use during surgery. The CONVIVO system is FDA-cleared, indicating it has passed safety checks for specific uses. It aids surgeons in distinguishing between healthy and tumor tissues in the brain. Overall, evidence supports its safety for patients undergoing brain tumor surgeries.¹²³⁴⁵

CONVIVO Endomicroscopy is unique because it offers a real-time, high-resolution view of brain tissue during surgery. Unlike traditional imaging methods, which can be time-consuming and less precise, this technique allows surgeons to make quicker and more accurate decisions about tumor boundaries. Researchers are excited about this technology because it has the potential to improve the precision of brain tumor surgeries, potentially leading to better outcomes and fewer complications for patients.

Research has shown that the CONVIVO Endomicroscopy system holds promise for brain tumor surgery. In earlier studies, this technology identified tumor edges with about 85.8% accuracy, a sensitivity of 89.6%, and a specificity of 79.4%. Another study found that integrating an AI model with this system increased the accuracy rate to 94% in detecting tumors. The system also provides real-time images, enabling doctors to differentiate between healthy and abnormal brain tissues during surgery. This capability can improve surgical outcomes by reducing the time required for traditional tissue analysis.¹²⁴⁶⁷